Severity scoring index for crimean-congo hemorrhagic fever and the impact of ribavirin and corticosteroids on fatality

Clinical Infectious Diseases

Volumn 57, Issue 9, 2013, Pages 1270-1274

  Dokuzoguz, Başak ^a   Celikbas, Aysel Kocagül ^a   Gök, Şebnem Eren ^a   Baykam, Nurcan ^a   Eroglu, Mustafa Necati ^a   Ergönül, Önder ^b  

^a ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b KOÇ UNIVERSITY   (Turkey)

Author keywords

corticosteroids; Crimean Congo hemorrhagic fever; ribavirin; severity scoring index

Indexed keywords

DEXAMETHASONE; FIBRINOGEN; FRESH FROZEN PLASMA; RIBAVIRIN;

ADOLESCENT; ADULT; AGED; AMYLASE BLOOD LEVEL; ANTIVIRAL THERAPY; ARTICLE; BLEEDING; BLEEDING TIME; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CRIMEAN CONGO HEMORRHAGIC FEVER; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE SEVERITY; DRUG EFFICACY; DRUG FATALITY; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE CONCENTRATE; ERYTHROCYTE TRANSFUSION; FATALITY; FEMALE; FIBRINOGEN BLOOD LEVEL; GASTROINTESTINAL HEMORRHAGE; HOSPITAL PATIENT; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PARTIAL THROMBOPLASTIN TIME; PLASMA TRANSFUSION; PREDICTIVE VALUE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SEVERITY SCORING INDEX; SIDE EFFECT; SOMNOLENCE; THROMBOCYTE COUNT; TREATMENT DURATION;

CORTICOSTEROIDS; CRIMEAN-CONGO HEMORRHAGIC FEVER; RIBAVIRIN; SEVERITY SCORING INDEX;

ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS; ANTIVIRAL AGENTS; FEMALE; HEMORRHAGIC FEVER, CRIMEAN; HUMANS; MALE; MIDDLE AGED; MORTALITY; PROGNOSIS; RIBAVIRIN; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84886887204     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cit527     Document Type: Article

References (13)

1. Ergonul O. Crimean-Congo haemorrhagic fever. Lancet Infect Dis 2006; 6:203-14.
2. Ergonul O, Celikbas A, Baykam N, Eren S, Dokuzoguz B. Analysis of risk-factors among patients with Crimean-Congo haemorrhagic fever virus infection: Severity criteria revisited. Clin Microbiol Infect 2006; 12:551-4.
3. Ergonul O. DEBATE (see Elaldi N et al, Efficacy of oral ribavirin treatment in Crimean-Congo haemorrhagic fever: A quasi-experimental study from Turkey. Journal of Infection 2009; 58: 238-244
4. Biases and misinterpretation in the assessment of the efficacy of oral ribavirin in the treatment of Crimean-Congo hemorrhagic fever. J Infect 2009; 59:284-6; author reply 6-9.
5. Swanepoel R, Gill DE, Shepherd AJ, Leman PA, Mynhardt JH, Harvey S. The clinical pathology of Crimean-Congo hemorrhagic fever. Rev Infect Dis 1989; 11(Suppl 4):S794-800.
6. Ergonul O, Tuncbilek S, Baykam N, Celikbas A, Dokuzoguz B. Evaluation of serum levels of interleukin (IL)-6, IL-10, and tumor necrosis factor-alpha in patients with Crimean-Congo hemorrhagic fever. J Infect Dis 2006; 193:941-4.
7. Ergonul O, Celikbas A, Dokuzoguz B, Eren S, Baykam N, Esener H. Characteristics of patients with Crimean-Congo hemorrhagic fever in a recent outbreak in Turkey and impact of oral ribavirin therapy. Clin Infect Dis 2004; 39:284-7.
8. Mardani M, Jahromi MK, Naieni KH, Zeinali M. The efficacy of oral ribavirin in the treatment of crimean-congo hemorrhagic fever in Iran. Clin Infect Dis 2003; 36:1613-8.
9. Ozkurt Z, Kiki I, Erol S, et al. Crimean-Congo hemorrhagic fever in Eastern Turkey: Clinical features, risk factors and efficacy of ribavirin therapy. J Infect 2006; 52:207-15.
10. Bausch DG, Hadi CM, Khan SH, Lertora JJ. Review of the literature and proposed guidelines for the use of oral ribavirin as postexposure prophylaxis for Lassa fever. Clin Infect Dis 2010; 51:1435-41.
11. Ergonul O. Treatment of Crimean-Congo hemorrhagic fever. Antiviral Res 2008; 78:125-31.
12. Arda B, Aciduman A, Johnston JC. A randomised controlled trial of ribavirin in Crimean Congo haemorrhagic fever: Ethical considerations. J Med Ethics 2012; 38:117-20.
13. Tasdelen Fisgin N, Fisgin T, Tanyel E, et al. Crimean-Congo hemorrhagic fever: Five patients with hemophagocytic syndrome. Am J Hematol 2008; 83:73-6.